References
- Bischof M, Bernroider E, Krssak M, Krebs M, Stingl H, Nowotny P, Yu C, Shulman G, Waldhausl W, Roden M. Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycemia. Diabetes/Metabol Res Rev 2002; 51: 49–54
- Damgé C, Maincent P, Ubrich N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Rel 2007; 117: 163–70
- Damgé C, Michel C, Aprahamian M, Couvreur P. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 1988; 37: 246–51
- Delgado T, Pinheiro D, Caldeira M, Castro M, Geraldes C, López-Larrubia P, Cerdán S, Jones J. Sources of hepatic triglyceride accumulation during high-fat feeding in the healthy rat. NMR Biomed 2009; 22: 310–17
- Fernandes A, Novelli E, Okoshi K, Okoshi M, Muzio B, Guimarães J, Junior A. Influence of rutin treatment on biochemical alteration in experimental diabetes. Biomed Pharmacother 2010; 64: 214–19
- Fernandez-Urrusuno R, Fatal E, Porquet D, Feger J, Couvreur P. Evaluation of liver toxicological effects induced by polyalkylcyanoacrylate nanoparticles. Toxicol Appl Pharmacol 1995; 130: 272–9
- Ferrer JC, Favre C, Gomis RR, Fernandez-Novell JM, Garca-Rocha M, Iglesia Ndl, Cid E, Guinovart JJ. Control of glycogen deposition. FEBS Lett 2003; 546: 127–32
- Jin ES, Uyeda K, Kawaguchi T, Burgess SC, Malloy CR, Sherry AD. Increased hepatic fructose 2,6-bisphosphate after an oral glucose load does not affect gluconeogenesis. J Biol Chem. 2003; 278: 28427–33
- Jones J. Tracing hepatic glucose and glycogen fluxes with 2H2O. Clinical diabetes research: Methods and techniques, M Roden. Wiley-Blackwell Press, London 2007; 139–49
- Jones JG, Barosa C, Gomes F, Mendes AC, Delgado TC, Diogo L, Garcia P, Bastos M, Barros L, Fagulha A, et al. NMR derivatives for quantification of 2H and 13C-enrichment of human glucuronide from metabolic tracers. J Carbohydr Chem 2006a; 25: 203–217
- Jones JG, Carvalho RA, Sherry AD, Malloy CR. Quantitation of gluconeogenesis by 2H nuclear magnetic resonance analysis of plasma glucose following ingestion of 2H2O. Anal Biochem 2000; 277: 121–6
- Jones JG, Fagulha A, Barosa C, Bastos M, Barros L, Baptista C, Caldeira MM, Carvalheiro M. Noninvasive analysis of hepatic glycogen kinetics before and after breakfast with deuterated water and acetaminophen. Diabetes 2006b; 55: 2294–300
- Jones JG, Merritt M, Malloy C. Quantifying tracer levels of 2H2O enrichment from microliter amounts of plasma and urine by 2H NMR. Magnetic Res Med 2001; 45: 156–8
- Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC. Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 1996; 98: 378–85
- Mithieux G, Rajas F, Gautier-Stein A. A novel role for glucose 6-phosphatase in the small intestine in the control of glucose homeostasis. J Biol Chem 2004; 279: 44231–4
- Newgard CB. Regulation of glucose metabolism in the liver. International textbook of diabetes mellitus, RA DeFronzo, E Ferrannini, H Keen, P Zimmet. Jonh Wiley & Sons, Chinchester 2004; 253–75
- Newgard CB, Hirsch LJ, Foster DW, McGarry JD. Studies on the mechanism by which exogenous glucose is converted into liver glycogen in the rat. J Biol Chem 1983; 258: 8046–8052
- Perdigoto R, Furtado AL, Porto A, Rodrigues TB, Geraldes CFGC, Jones JG. Sources of glucose production in cirrhosis by 2H2O ingestion and 2H NMR analysis of plasma glucose. Biochim Biophys Acta 2003a; 1637: 156–63
- Perdigoto R, Rodrigues TB, Furtado AL, Porto A, Geraldes C, Jones J. Integration of [U-13C]glucose and 2H2O for quantification of hepatic glucose production and gluconeogenesis. NMR Biomed 2003b; 16: 189–198
- Prego C, Torres D, Fernandez-Megia E, Novoa-Carballal R, Quinoa E, Alonso MJ. Chitosan-PEG nanocapsules as new carriers for oral peptide delivery: Effect of chitosan pegylation degree. J Control Rel 2006; 111: 299–308
- Radziuk J, Pye S, Seigler D, Skyler J, Offord R, Davies G. Splanchnic and systemic absorption of intraperitoneal insulin using a new double-tracer method. Am J Physiol-Endoc 1994; M266: E750–9
- Reis CP, Figueiredo IV, Carvalho RA, Jones J, Nunes P, Soares AF, Veiga FJ, Damgé D, Cabrita AMS, Neufeld RJ. Toxicological assessment of orally delivered nanoparticulate insulin. Nanotoxicology 2008b; 2: 205–17
- Reis CP, Ribeiro AJ, Houng S, Veiga F, Neufeld RJ. Nanoparticulate delivery system for insulin: Design, characterization and in vitro/in vivo bioactivity. Eur J Pharm Sci 2007; 30: 392–7
- Reis CP, Ribeiro AJ, Neufeld RJ, Veiga F. Alginate microparticles as novel carrier for oral insulin delivery. Biotechnol Bioeng 2006; 96: 977–89
- Reis CP, Ribeiro AJ, Veiga F, Neufeld RJ, Damgé C. Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery. Drug Deliv 2008c; 15: 127–39
- Reis CP, Veiga FJ, Ribeiro AJ, Neufeld RJ, Damgé C. Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response. J Pharm Sci 2008a; 97: 5290–305
- Ribeiro A, Caldeira MM, Carvalheiro M, Bastos M, Baptista C, Fagulha A, Barros L, Barosa C, Jones JG. Simple measurement of gluconeogenesis by direct 2H NMR analysis of menthol glucuronide enrichment from 2H2O. Magnetic Res Med 2005; 54: 429–34
- Wi JK, Kim JK, Young J. Mechanisms of postabsorptive hyperglycemia in streptozotocin diabetic rats. Am J Physiol 1996; 270: E752–8